Apogee Therapeutic

Forecast & Rating15 analysts currently cover Apogee Therapeutic, with about 6.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $134.85, about 0.2% downside from the current price of $135.07. Price targets are fairly clustered, pointing to relatively aligned views. Historically, about 50.6% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Apogee Therapeutic's outlook. Data as of Sep 3, 2026; for reference only and not investment advice.